Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 May;62(2):e333-e334.
doi: 10.1111/ajd.13504. Epub 2020 Nov 20.

Pityriasis rosea-like eruption revealing COVID-19

Affiliations
Case Reports

Pityriasis rosea-like eruption revealing COVID-19

Stefano Veraldi et al. Australas J Dermatol. 2021 May.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patient 1. Several erythematous‐squamous papules and plaques located on the upper limbs and back.
Figure 2
Figure 2
Patient 2. (a) Herald patch. (b) Widespread erythematous‐squamous rash on the chest, with lesions of different morphology and size.

References

    1. Drago F, Broccolo F, Rebora A. Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology. J. Am. Acad. Dermatol. 2009; 61: 303–18. - PubMed
    1. Drago F, Ciccarese G, Rebora A et al. Pityriasis rosea: a comprehensive classification. Dermatology 2016; 232: 431–7. - PubMed
    1. Gianotti R, Veraldi S, Recalcati S et al. Cutaneous clinico‐pathological findings in three COVID‐19‐positive patients observed in the metropolitan area of Milan, Italy. Acta Derm. Venereol. 2020;100:adv00124. - PMC - PubMed
    1. Sachdeva M, Gianotti R, Shah M et al. Cutaneous manifestations of COVID‐19: report of three cases and a review of literature. J. Dermatol. Sci. 2020; 98: 75–81. - PMC - PubMed
    1. Ehsani AH, Nasimi M, Bigdelo Z. Pityriasis rosea as a cutaneous manifestation of COVID‐19 infection. J. Eur. Acad. Dermatol. Venereol. 2020. 10.1111/jdv.16579. - DOI - PMC - PubMed